EP3984537
CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.12.2014EP published:
20.3.2024EP application number:
21193832.9
EPO information:
European Patent Register
Max expiry date:
18.12.2034
Title in English:
CANCER TREATMENTS USING COMBINATIONS OF TYPE 2 MEK AND ERK INHIBITORSLanguage of the patent:
English
Timeline
Today
19.12.2014EP application
20.3.2024EP Publication
Owner
Name:
Biomed Valley Discoveries, Inc.Address:
4435 Main Street Suite 550, Kansas City, Missouri 64111, US
Inventor
Name:
SAHA, SaurabhAddress:
Massachusetts, 02481, US
Name:
WELSCH, DeanAddress:
Missouri, 64152, US
Name:
DECRESCENZO, GaryAddress:
Missouri, 64152, US
Name:
ROIX, Jeffrey JamesAddress:
London, W1G 7BB, GB
Priority
Number:
201361919625 PDate:
20.12.2013Country:
US
Classification
Categories:
A61K 31/4439, A61K 31/506, A61K 31/519, A61K 31/437, A61K 31/337, A61P 35/00